MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/ndt.s185757

Медицинская библиотека · Neuropsychiatric disease and treatment · 2020

Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives.

Atmaca Murad

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Any type of sexual dysfunction is an important problem in half of the patients with depressive disorder. On the other hand, one to a quarter of people without any depressive disorder experience sexual dysfunction. Antidepressant agents can lead to all types of sexual side effects including arousal, libido, orgasm and ejaculation problems. Selective serotonin reuptake inhibitors (SSRIs) are a widely used class of drugs which are prescribed for the treatment of a variety of disorders, including major depressive disorder, obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, generalized anxiety disorder, and impulse control disorders. It has been reported that one in eight people have utilized one of the SSRIs in the past 10 years. Some studies reported up to 80% of SSRI-induced sexual side effects. Management of SSRI-induced sexual dysfunction seems to be complex and hard. In this paper, SSRI-induced sexual dysfunction and new perspectives in the management of this problem were reviewed.

Для цитирования: Atmaca Murad. Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives.. Neuropsychiatric disease and treatment. 2020. DOI: 10.2147/ndt.s185757.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.